CSRC vows deeper reforms to open China’s capital market and boost tech listings


China’s top securities regulator has pledged to widen foreign investors’ access to the mainland’s capital market while further lowering the fundraising threshold for technology firms, after a key indicator slumped nearly 4 per cent from a 10-year high in mid-November.
Wu Qing, chairman of the China Securities Regulatory Commission (CSRC), set out guidance for the equity and bond markets in an article published by the Communist Party mouthpiece People’s Daily on Friday, three weeks after he was reported to have offered his resignation.

The Chinese capital market requires a “deep transformation” to enhance its “inclusiveness and adaptability”, Wu said, calling for a regulatory environment where medium and long-term funds “are willing to come, can stay and can develop well” amid market volatility.

He also highlighted the role of private equity and venture capital, pledging to smooth the “fundraising, investment, management and exit” cycle to ensure efficient capital flows into strategic sectors.

“The article aims to bolster domestic and international investors’ confidence in China’s capital markets,” said Ding Haifeng, a consultant at Shanghai-based financial ­advisory firm Integrity. “It also reaffirms Wu’s role in leading the regulatory commission despite speculation about his resignation.”

Wu Qing’s article aims to bolster domestic and international investors’ confidence in China’s capital market, according to an analyst. Photo: EPA
Wu Qing’s article aims to bolster domestic and international investors’ confidence in China’s capital market, according to an analyst. Photo: EPA

The benchmark Shanghai Composite Index hit a 10-year high in November, closing at 4,029.5, up 20.2 per cent from last year’s close, buoyed by a trade truce between Beijing and Washington and heightened expectations for improved company fundamentals.

  • Related Posts

    China’s AI red-packet battle burns through US$1 billion – but will users stick around?

    In an unprecedented Chinese New Year marketing blitz, Alibaba Group Holding, Baidu, ByteDance and Tencent Holdings spent an estimated 8 billion yuan (US$1.1 billion) to turn their artificial intelligence assistants…

    Continue reading
    Chinese AI drug researcher XtalPi expects to turn first annual profit on 193% revenue jump

    Chinese artificial intelligence-powered drug researcher XtalPi Holdings said it expects to turn its first annual profit on the back of strong revenue growth, according to a corporate filing. The Shenzhen-based…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *